AFP is a biomarker for neurodegenerative diseases (like cerebellar ataxia) [21], and is considered to potentially promote repair after neural injury by regulating neurogenesis‐related signalling pathways [22]. The gene discussed is AFP; the disease is aceruloplasminemia.